newsCHMP meeting highlights – July 202429 July 2024 | By Catherine Eckford (European Pharmaceutical Review)In its July meeting, the EMA’s human medicines committee recommended 14 medicines and held a negative opinion for authorising lecanemab to treat Alzheimer’s disease.